Product News

NMN alleviates retina damage by reducing senescent (aged) cells in age-related macular degeneration models.

Chinese scientists find that NMN restores the age-related deterioration of the intestinal wall by boosting natural antioxidant defenses and reducing inflammation in older mice.

Researchers in China show that the NAD+ precursor NMN and antioxidant resveratrol boosts the cognition of aged rats by their senolytic action.

By improving mitochondrial production and functional capacity, NMN with troxerutin fully protects the heart against the toxic effects of the chemotherapeutic doxorubicin in rats.

Administering NMN with resveratrol synergistically boosts NAD+ in the heart and skeletal muscle of mice, while combining NMN with ginsenosides amplifies NAD+ in the lungs.

Treating obese female mice with nicotinamide mononucleotide (NMN) reduces DNA damage and improves structural protein composition within egg cells (oocytes) while restoring low offspring birth weight.

Chinese scientists find that boosting NAD+ with its precursor, NMN improves the learning and memory of a mouse model for Alzheimer’s disease.

A new study finds that NMN improves the metabolism, hormone levels, and skin of postmenopausal women.

A study from the Brain Mind Institute at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland show that nicotinamide mononucleotide (NMN) may help overweight kids and young adults going through puberty with sociability and early life stress by o

Treating human cells with NMN triples NAD+ levels and increases the activity of AMPK — an enzyme that turns on sugar and fat metabolism in response to low energy.

Research from Sichuan University shows that NAD+ is indispensable for stem cells from bone marrow to repair fractures.

Researchers from Zhejiang University School of Medicine show that the NAD+ precursor NMN enhances the ability of brain cells to generate myelin — the protective insulation coating nerve projections — in naturally and prematurely aged mice.

Scientists find that boosting NAD+ with NMN and NR supplementation alleviates diabetes-related nerve fiber degeneration and loss in rodents.

Nicotinamide mononucleotide (NMN)-treated antitumor CAR-T cells display enhanced effectiveness to combat cancer cells and reduce tumor growth in mice.

Nicotinamide mononucleotide (NMN)-treated antitumor immune cells display enhanced and sustained effectiveness to combat cancer cells and reduce tumor growth in mice.

Researchers from the Washington University School of Medicine in St. Louis show that the enzyme behind NMN biosynthesis – NAMPT – reversion metabolic derangements in obese mice.

A recently-published University of Toyama study from Japan reveals that a daily intake of 250 mg of nicotinamide mononucleotide (NMN) significantly raises blood NAD+.